Vivanza Biosciences Balance Sheet Health
Financial Health criteria checks 2/6
Vivanza Biosciences has a total shareholder equity of ₹49.2M and total debt of ₹62.4M, which brings its debt-to-equity ratio to 126.8%. Its total assets and total liabilities are ₹219.6M and ₹170.4M respectively. Vivanza Biosciences's EBIT is ₹6.0M making its interest coverage ratio 1.6. It has cash and short-term investments of ₹1.7M.
Key information
126.8%
Debt to equity ratio
₹62.39m
Debt
| Interest coverage ratio | 1.6x |
| Cash | ₹1.71m |
| Equity | ₹49.20m |
| Total liabilities | ₹170.38m |
| Total assets | ₹219.57m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530057's short term assets (₹181.6M) exceed its short term liabilities (₹142.1M).
Long Term Liabilities: 530057's short term assets (₹181.6M) exceed its long term liabilities (₹28.3M).
Debt to Equity History and Analysis
Debt Level: 530057's net debt to equity ratio (123.3%) is considered high.
Reducing Debt: 530057's debt to equity ratio has increased from 25.5% to 126.8% over the past 5 years.
Debt Coverage: 530057's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 530057's interest payments on its debt are not well covered by EBIT (1.6x coverage).